Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Ott, Beate ^a,b   Skurk, Thomas ^a,b   Hastreiter, Ljiljana ^a   Lagkouvardos, Ilias ^b   Fischer, Sandra ^b   Büttner, Janine ^c   Kellerer, Teresa ^a   Clavel, Thomas ^b,d   Rychlik, Michael ^b   Haller, Dirk ^b   Hauner, Hans ^a,b,e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD ANALYSIS; CALORIC RESTRICTION; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMAN; INFLAMMATION; INTESTINE FLORA; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; OBESITY; PATHOLOGY; PERMEABILITY; TREATMENT OUTCOME;

ADULT; BLOOD CHEMICAL ANALYSIS; CALORIC RESTRICTION; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; MICROBIOTA; MIDDLE AGED; OBESITY; PERMEABILITY; TREATMENT OUTCOME;

EID: 85029663548     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-12109-9     Document Type: Article

References (57)

1. Kahn, S. E., Hull, R. L. & Utzschneider, K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444, 840-846 (2006).
2. Shoelson, S. E., Lee, J. & Goldfine, A. B. Inflammation and insulin resistance. The Journal of clinical investigation 116, 1793-1801 (2006).
3. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. The New England journal of medicine 352, 1685-1695 (2005).
4. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of clinical investigation 112, 1796-1808 (2003).
5. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of clinical investigation 112, 1821-1830 (2003).
6. Skurk, T. & Alberti-Huber, C. Herder, C. & Hauner, H. Relationship between adipocyte size and adipokine expression and secretion. The Journal of clinical endocrinology and metabolism 92, 1023-1033 (2007).
7. Teixeira, T. et al. Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clinical nutrition (Edinburgh, Scotland) 31, 735-740 (2012).
8. Creely, S. J. et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. American journal of physiology. Endocrinology and metabolism 292, E740-7 (2007).
9. Cani, P. D. et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470-1481 (2008).
10. Falony, G. et al. Population-level analysis of gut microbiome variation. Science (New York, N.Y.) 352, 560-564 (2016).
11. Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023 (2006).
12. Zhang, H. et al. Human gut microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences of the United States of America 106, 2365-2370 (2009).
13. Schwiertz, A. et al. Microbiota and SCFA in lean and overweight healthy subjects, Obesity (Silver Spring, Md.) 18, 190-195 (2010).
14. Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103 (2009).
15. de La Serre, C. B. et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. American journal of physiology. Gastrointestinal and liver physiology 299, G440-8 (2010).
16. Moreno-Navarrete, J. M. et al. Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance. International journal of obesity (2005) 36, 1442-1449 (2012).
17. Cobden, I., Rothwell, J. & Axon, A. T. Intestinal permeability and screening tests for coeliac disease. Gut 21, 512-518 (1980).
18. Bjarnason, I., Peters, T. J. & Veall, N. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet (London, England) 1, 323-325 (1983).
19. Morales, M. T., Montaña, M. T., Galan, G. & Gomez Ariza, J. L. Spectrophotometric determination of bismuth in pharmaceutical preparations using 1-[di(2-pyridyl)-methylene]-5-salicylidene-thiocarbonohydrazide. Farmaco (Società chimica italiana: 1989) 45, 673-682 (1990).
20. Troncone, R., Caputo, N., Florio, G. & Finelli, E. Increased intestinal sugar permeability after challenge in children with cow's milk allergy or intolerance. Allergy 49, 142-146 (1994).
21. Cottam, D. R. et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obesity surgery 14, 589-600 (2004).
22. Clément, K. et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 18, 1657-1669 (2004).
23. Lehrke, M. et al. Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European journal of endocrinology 161, 339-344 (2009).
24. Bozaoglu, K. et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148, 4687-4694 (2007).
25. Fasano, A. et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet (London, England) 355, 1518-1519 (2000).
26. Xiao, S. et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 87, 357-367 (2014).
27. Fasano, A. Regulation of intercellular tight junctions by zonula occludens toxin and its eukaryotic analogue zonulin. Annals of the New York Academy of Sciences 915, 214-222 (2000).
28. Bassuk, S. S., Rifai, N. & Ridker, P. M. High-sensitivity C-reactive protein: clinical importance. Current problems in cardiology 29, 439-493 (2004).
29. Zhang, C. et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nature communications 4, 2163 (2013).
30. Forsythe, L. K. W., Julie, M. W. & Livingstone, M. Barbara E. Obesity and inflammation: the effects of weight loss. Nutrition research reviews 21, 117-133 (2008).
31. Verhoef, S. P. M. et al. Physiological response of adipocytes to weight loss and maintenance. PLoS ONE 8, e58011 (2013).
32. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
33. Cotillard, A. et al. Dietary intervention impact on gut microbial gene richness. Nature 500, 585-588 (2013).
34. Shin, N.-R., Whon, T. W. & Bae, J.-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends in biotechnology 33, 496-503 (2015).
35. Xiao, S. et al. A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS microbiology ecology 87, 357-367 (2014).
36. Allen-Vercoe, E. et al. Anaerostipes hadrus comb. nov. a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. Anaerobe 18, 523-529 (2012).
37. Kant, R. Rasinkangas, P. Satokari, R. Pietila, T. E. & Palva, A. Genome Sequence of the Butyrate-Producing Anaerobic Bacterium Anaerostipes hadrus PEL 85, Genome announcements 3 (2015).
38. Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-6.e7 (2012).
39. Derrien, M. & Veiga, P. Rethinking Diet to Aid Human-Microbe Symbiosis. Trends in microbiology 25, 100-112 (2017).
40. Baer, D. J. et al. The metabolizable energy of dietary resistant maltodextrin is variable and alters fecal microbiota composition in adult men. The Journal of nutrition 144, 1023-1029 (2014).
41. Santacruz, A. et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring, Md.) 17, 1906-1915 (2009).
42. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
43. Norman, K. et al. Increased intestinal permeability in malnourished patients with liver cirrhosis. European journal of clinical nutrition 66, 1116-1119 (2012).
44. Lichtenegger, M. & Rychlik, M. Development of a stable isotope dilution LC-MS assay for the quantitation of multiple polyethylene glycol (PEG) homologues to be used in permeability studies. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 1001, 182-190 (2015).
45. Dankel, S. N. et al. COL6A3 expression in adipocytes associates with insulin resistance and depends on PPARgamma and adipocyte size. Obesity (Silver Spring, Md.) 22, 1807-1813 (2014).
46. McCulloch, L. J. et al. COL6A3 is regulated by leptin in human adipose tissue and reduced in obesity. Endocrinology 156, 134-146 (2015).
47. Pfaffl, M. W., Horgan, G. W. & Dempfle, L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic acids research 30, e36 (2002).
48. Lagkouvardos, I. et al. Gut metabolites and bacterial community networks during a pilot intervention study with flaxseeds in healthy adult men. Molecular nutrition & food research 59, 1614-1628 (2015).
49. Klindworth, A. et al. Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencingbased diversity studies. Nucleic acids research 41, e1 (2013).
50. Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nature methods 10, 996-998 (2013).
51. Lagkouvardos, I. et al. IMNGS: A comprehensive open resource of processed 16S rRNA microbial profiles for ecology and diversity studies. Scientific reports 6, 33721 (2016).
52. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics (Oxford, England) 26, 2460-2461 (2010).
53. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic acids research 41, D590-6 (2013).
54. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Applied and Environmental Microbiology 73, 5261-5267 (2007).
55. Chen, J. et al. Associating microbiome composition with environmental covariates using generalized UniFrac distances. Bioinformatics (Oxford, England) 28, 2106-2113 (2012).
56. Jost, L. Partitioning diversity into independent alpha and beta components. Ecology 88, 2427-2439 (2007).
57. Lagkouvardos, I., Fischer, S., Kumar, N. & Clavel, T. Rhea: a transparent and modular R pipeline for microbial profiling based on 16S rRNA gene amplicons. PeerJ 5, e2836 (2017).